The hottest tech trades of 2026 just got slammed - smart investors are buying anyway Chip stocks have taken a beating - but there's reason to stay bullish. A bull market supported by several sectors ...

The August stock-market slump is a myth - so why does Wall Street keep repeating it?

Medtronic has historically held roughly 50% share in its core heart devices. It's also the market leader in spinal products, insulin pumps, and neuromodulators for chronic pain. Medtronic's Hugo robot ...

This High-Quality Stock Is on Sale; Should You Buy the Dip?

Medalist Rating covers product that tracks indices created or licensed by Morningstar. See Disclosure for more details.

Medalist Rating covers product that tracks indices created or licensed by Morningstar. See Disclosure for more details.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Will FBNDX outperform in the future? Get our overall rating based on a fundamental assessment of the pillars below.

The bond market hasn't been this calm since the dot-com bust and the financial crisis. History warns of a rude awakening.

AbbVie's next-generation immunology drugs targeting the IL-23 (Skyrizi) and JAK (Rinvoq) pathways are mitigating biosimilar headwinds to older blockbuster Humira. AbbVie has had to depend on ...